About AGIL Infirmiers
AGIL Infirmiers is a Healthcare company founded in 2021. It offers nursing care including injections, dressings, and hygiene at home or in cabinet. It operates on a B2C model. AGIL Infirmiers offers products and services including Home Nursing Care, In-Cabinet Nursing Services, and Vaccination Services. Its focus areas include Nursing Services, In-Cabinet Care, Appointment-Based Treatments and Home Care. Its competitors include Elivie, Orpea, Sante Cie, Ernesti and La Mut and 1 more; 2 of its 6 listed competitors have raised funding.
Company details
AGIL Infirmiers is a group of state-qualified liberal nurses providing essential healthcare services such as hygiene care, injections, vaccinations, dressings, and treatments. They operate in Neuilly-sur-Seine and Levallois-Perret, serving children, adults, and seniors through home visits or in-cabinet appointments. Services are available seven days a week, adhering to legal and sanitary standards, with a focus on personalized care in the Paris region.
- SectorsHealthcare
- Phone•••• ••••
- Website agilinfirmiers.com
Products & Services of AGIL Infirmiers
AGIL Infirmiers offers a comprehensive portfolio of products and services, including Home Nursing Care, In-Cabinet Nursing Services, and Vaccination Services.
Delivers treatments like injections and dressings at patients' homes
Provides hygiene and medical treatments in the clinic on appointment
Administers vaccines and preventive care at home or in cabinet
Competitors of AGIL Infirmiers
AGIL Infirmiers has 6 listed competitors in our database, 2 of them funded. They include Elivie, Orpea, Sante Cie, Ernesti and La Mut, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| elivie.fr | 2015 | Villeurbanne, France | $41.7M | – | Provider of home healthcare services | |
| orpea.com | 1989 | Puteaux, France | – | – | Diversified healthcare services are provided through nursing homes and clinics. | |
| santecie.com | 2015 | Villeurbanne, France | – | – | Local home healthcare services are delivered via ambulatory medicine. | |
| ernesti.fr | 2018 | Bordeaux, France | $366,029 | – | Diversified healthcare services are provided across various sectors. | |
| lamut.fr | 2010 | Le Tholonet, France | – | – | Offers optical, dental, hearing, childcare, and elderly care services across France. | |
| assad74.fr | 2019 | Gaillard, France | – | – | Provides home assistance services to support daily needs. |
Detailed competitors of AGIL Infirmiers
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Oncology
10 companies that operate in the same segment as AGIL Infirmiers (Oncology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Novel biopharmaceutical medicines are developed for unmet medical needs. | 2003 | Dublin, Ireland | USD 265 M | USD 4.27 B | 2,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed. | 2002 | Saint-genis-pouilly, Ain, France | USD 56.13 M | USD 235.08 M | – | |
Developer of small molecule drugs for the treatment of cancer and inflammatory disease | 2008 | Natick, Massachusetts, United States | USD 98.4 M | USD 146.07 M | 279 | |
Small molecule therapeutics are developed for cancer and rare diseases. | 2017 | New York, New York, United States | USD 229.6 M | – | – | |
Small-molecule drugs for cancer treatment are developed via Degronimid platform. | 2016 | Cambridge, Massachusetts, United States | USD 223 M | USD 35.95 M | 110 | |
Developer of drugs based on T-Cell receptor technology for the treatment of cancer | 2008 | Abingdon, Oxfordshire, United Kingdom | USD 601.28 M | USD 400.95 M | 493 | |
Antibody-based drugs are developed for autoimmune diseases and cancer treatment. | 2008 | Ghent, East Flanders, Belgium | USD 61.9 M | USD 1.41 B | 355 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about AGIL Infirmiers
AGIL Infirmiers was founded in 2021.
AGIL Infirmiers is a group of state-qualified liberal nurses providing essential healthcare services such as hygiene care, injections, vaccinations, dressings, and treatments. They operate in Neuilly-sur-Seine and Levallois-Perret, serving children, adults, and seniors through home visits or in-cabinet appointments. Services are available seven days a week, adhering to legal and sanitary standards, with a focus on personalized care in the Paris region.
AGIL Infirmiers offers Home Nursing Care, In-Cabinet Nursing Services, and Vaccination Services.